SuperworthAlaunos Therapeutics shares outstanding TCRT
Diluted shares outstanding, averaged over each quarter, from 2009.
- Latest quarter, to Jun 30, 2026
- 2.4M
- On a year earlier
- +45.1%
- more shares
Alaunos Therapeutics had 2.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 45.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 2.3M | +45% |
| FY2024 | 1.6M | −0% |
| FY2023 | 1.6M | +8% |
| FY2022 | 1.5M | +4% |
| FY2021 | 1.4M | +1% |
| FY2020 | 1.4M | +19% |
| FY2019 | 1.2M | +19% |
| FY2018 | 1M | +7% |
| FY2017 | 937.6K | +8% |
| FY2016 | 870.2K | +0% |
| FY2015 | 865.9K | +26% |
| FY2014 | 689.4K | +9% |
| FY2013 | 630.2K | +16% |
| FY2012 | 542.3K | +19% |
| FY2011 | 454.4K | +26% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 2.4M | +45% | |
| Q1 FY26 | 1.9M | +22% | |
| Q4 FY25 | 2.3M | +45% | |
| Q3 FY25 | 2.2M | +36% | |
| Q2 FY25 | 1.7M | +5% | |
| Q1 FY25 | 1.6M | +0% | |
| Q4 FY24 | 1.6M | −0% | |
| Q3 FY24 | 1.6M | +0% | |
| Q2 FY24 | 1.6M | +0% | |
| Q1 FY24 | 1.6M | +0% | |
| Q4 FY23 | 1.6M | +8% | |
| Q3 FY23 | 1.6M | +12% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Alaunos Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.